Phase I Clinical Trial of 68Ga-NOTA-SNA002

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

November 8, 2024

Study Completion Date

November 8, 2024

Conditions

Solid TumorPositron-Emission Tomography(PET)

Interventions

DRUG

68Ga-NOTA-SNA002

68Ga-NOTA-SNA002 should be injected intravenously slowly for no less than 1min.

Trial Locations (1)

Zhongshan Hospital Affiliated to Fudan University, Shanghai